About
Cynapsus Therapeutics Inc. develops a fast-acting, easy-to-use sublingual thin film formulation of apomorphine for the on-demand treatment of OFF episodes in Parkinson's disease patients.
Explore Cynapsus Therapeutics Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.